Literature DB >> 35593976

Age-related immunosenescence in Behçet's disease.

Döndü Üsküdar Cansu1, Cengiz Korkmaz2.   

Abstract

Behçet's disease (BD) is a systemic vasculitis of unknown etiology causing recurrent mucocutaneous lesions, ocular involvement, central nervous system involvement, and vascular involvement. The disease is characterized by exacerbations and spontaneous remissions. Prognosis is poor in young men when the vessels are involved. The course is more active and severe in the first years of the disease. One of the most interesting features of BD is that the disease changes to a state of low activity and remission over time. Although the association between aging and lower disease activity is well established, there is limited literature data and research investigating the cause. Similarly, there are not many studies on the late onset of BD and its characteristics. In this regard, understanding the cause of the decline in disease activity over time may open new avenues for pathogenesis and treatment research. In this review, we focus on the immunosenescence caused by chronic inflammation and aging in BD. Based on the effect of testosterone on innate immune cells, we also briefly discussed the potential effects of this hormone on vascular involvement.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aging; Behçet’s disease; Immunosenescence; Inflammaging; Late onset

Mesh:

Year:  2022        PMID: 35593976     DOI: 10.1007/s00296-022-05144-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  54 in total

Review 1.  Inflamm-aging. An evolutionary perspective on immunosenescence.

Authors:  C Franceschi; M Bonafè; S Valensin; F Olivieri; M De Luca; E Ottaviani; G De Benedictis
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

Review 2.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-03       Impact factor: 20.543

3.  Venous involvement in inflammatory disorders.

Authors:  Emire Seyahi
Journal:  Curr Opin Rheumatol       Date:  2020-01       Impact factor: 5.006

Review 4.  Phenotypes in Behçet's syndrome.

Authors:  Emire Seyahi
Journal:  Intern Emerg Med       Date:  2019-02-11       Impact factor: 3.397

Review 5.  Immunopathogenesis of Behçet's disease and treatment modalities.

Authors:  T B van der Houwen; P M van Hagen; J A M van Laar
Journal:  Semin Arthritis Rheum       Date:  2022-01-10       Impact factor: 5.532

6.  Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis.

Authors:  Banu Kara Kivanc; Emel Gönüllü; Olga Meltem Akay; Adem Ertürk; Cengiz Bal; Döndü Üskudar Cansu; Cengiz Korkmaz
Journal:  Clin Exp Rheumatol       Date:  2018-06-08       Impact factor: 4.473

Review 7.  Vascular Behçet's syndrome: an update.

Authors:  Giacomo Emmi; Alessandra Bettiol; Elena Silvestri; Gerardo Di Scala; Matteo Becatti; Claudia Fiorillo; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

Review 8.  Vascular involvement in Behçet's disease: the immunopathological process.

Authors:  Raquelle Machado de Vargas; Maria Luiza Nunes da Cruz; Maria Paula Hashimoto Giarllarielli; Beatriz Mota Sano; Geovana Idelfoncio da Silva; Karina Furlani Zoccal; Cristiane Tefé-Silva
Journal:  J Vasc Bras       Date:  2021-07-05

9.  A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Authors:  E Khan; N L Ambrose; J Ahnström; A P Kiprianos; M R Stanford; D Eleftheriou; P A Brogan; J C Mason; M Johns; M A Laffan; D O Haskard
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.